首页> 外国专利> A composition for the prevention or treatment of acute graft-versus-host disease comprising, as an active ingredient, prodigiosin isolated by Serratia marcescens B-1231KCTC0386BP

A composition for the prevention or treatment of acute graft-versus-host disease comprising, as an active ingredient, prodigiosin isolated by Serratia marcescens B-1231KCTC0386BP

机译:预防或治疗急性移植物抗宿主病的组合物,其包含作为活性成分的粘质沙雷氏菌B-1231KCTC0386BP

摘要

This invention relates to a composition for the prevention and treatment of acute graft-versus-host disease comprising prodigiosin isolated from Serratia marcescence B-1231 KCTC 0386BP, as an effective ingredient. The prodigiosin is immunosup-pressive by selectively suppressing the proliferation of T-cells through the suppression of the expression of IL-2 receptors, which is needed for the activation of T-cells. Prodigiosin can be used either alone or in conjunction with cyclosporin A for greater effect, since the two substances have different mode of actions. These make prodigiosin effective for the prevention and treatment of acute graft-versus-host disease.
机译:本发明涉及一种用于预防和治疗急性移植物抗宿主病的组合物,该组合物包含从粘质沙雷氏菌B-1231 KCTC 0386BP中分离出的prodigiosin作为有效成分。通过抑制IL-2受体的表达来选择性地抑制T细胞的增殖,从而使prodigiosin具有免疫抑制作用,这是激活T细胞所必需的。 Prodigiosin可单独使用或与环孢菌素A结合使用,以产生更大的效果,因为这两种物质具有不同的作用方式。这些使prodigiosin对预防和治疗急性移植物抗宿主病有效。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号